BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/18/2026 11:03:40 AM | Browse: 0 | Download: 0
Publication Name World Journal of Diabetes
Manuscript ID 125765
DOI 10.4239/wjd.125765
Country China
Category Endocrinology & Metabolism
Manuscript Type Retrospective Cohort Study
Article Title Ticagrelor vs clopidogrel on vein graft patency in patients with diabetes undergoing coronary artery bypass grafting
Manuscript Source Unsolicited Manuscript
All Author List Rui-Jun Yuan, Keng Zhong, Jie Lu, Xing-Li Fan, Zhi-Min Zhao, Wen-Wen Li, Jiao-Na Qiu, Guan-Xin Zhang and Qing Xue
Funding Agency and Grant Number
Funding Agency Grant Number
The Clinical Research Special Project of Shanghai Municipal Health Commission No. 202240358
National Natural Science Foundation of China No. 82470444
The Funding of Basic Medical Research Project of Changhai Hospital No. 2023PY05
Chang Jian Leading Talent Prospect of Changhai Hospital No. 2024CF002
Demonstration of Clinical Application of Innovative Medical Devices under Shanghai High-Quality Development Plan for Science and Technology Industry No. 25SF1908305
Corresponding Author Qing Xue, Professor, Department of Cardiovascular Surgery, Shanghai Changhai Hospital, The First Affiliated Hospital of Naval Medical University, No. 168 Changhai Road, Shanghai 200433, China. chyyxwkxq@163.com
Key Words Type 2 diabetes mellitus; Coronary artery bypass grafting; Ticagrelor; Clopidogrel; Saphenous vein graft patency
Core Tip In this retrospective cohort of patients with type 2 diabetes mellitus undergoing coronary artery bypass grafting, ticagrelor plus aspirin was associated with better 5-year saphenous vein graft patency than clopidogrel plus aspirin. No statistically significant differences in major adverse cardiovascular events or bleeding events were observed, but the study was underpowered for safety outcomes. These findings suggest a potential benefit of ticagrelor for saphenous vein graft patency in this high-risk population, warranting confirmation in prospective randomized trials.
Citation Yuan RJ, Zhong K, Lu J, Fan XL, Zhao ZM, Li WW, Qiu JN, Zhang GX, Xue Q. Ticagrelor vs clopidogrel on vein graft patency in patients with diabetes undergoing coronary artery bypass grafting. World J Diabetes 2026; In press
Received
2026-08-07 11:52
Peer-Review Started
2026-08-17 00:20
First Decision by Editorial Office Director
Return for Revision
2026-09-02 09:26
Revised
2026-09-22 07:35
Publication Fee Transferred
Editorial Processing by Scientific Editor
2026-11-11 02:44
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2026-11-18 11:03
Articles in Press
2026-11-18 11:03
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-9358 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com